GeneDx Announces Transformative Study Supporting Hospital-Wide Adoption of Rapid Genomic Sequencing at Seattle Children’s
GeneDx and Seattle Children’s published a study in Genetics in Medicine evaluating rapid genome sequencing (rGS) across more than 1,000 pediatric inpatients over 3.5 years. The study found a 35% overall diagnostic yield, rising to 63% for children with faltering growth and 43% in non-ICU wards, demonstrating utility beyond traditional critical care settings.
Key figures
- Inpatients evaluated
- >1,000
- Study duration years
- 3.5
- Faltering growth yield
- 63%
- Non icu diagnostic yield
- 43%
- Overall diagnostic yield
- 35%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.